Versigent (NYSE:VGNT) Given Consensus Rating of “Buy” by Analysts

Versigent (NYSE:VGNT) has been assigned a consensus rating of “Buy” from the thirteen research firms that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and three have issued a strong buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $49.6667.

VGNT has been the topic of a number of recent analyst reports. Royal Bank Of Canada lifted their price objective on Versigent from $34.00 to $41.00 and gave the stock a “sector perform” rating in a research report on Monday, July 13th. Argus set a $50.00 target price on Versigent in a research note on Tuesday, July 21st. UBS Group decreased their target price on Versigent from $58.00 to $55.00 and set a “buy” rating for the company in a report on Thursday, July 9th. Fox Advisors raised Versigent to a “strong-buy” rating in a research note on Tuesday, April 7th. Finally, Zacks Research upgraded shares of Versigent from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 2nd.

Versigent Price Performance

Shares of VGNT opened at $41.33 on Monday. Versigent has a fifty-two week low of $26.34 and a fifty-two week high of $50.88. The business has a 50 day simple moving average of $43.27.